587 related articles for article (PubMed ID: 11702296)
1. Management of androgenetic alopecia.
Bolduc C; Shapiro J
Am J Clin Dermatol; 2000; 1(3):151-8. PubMed ID: 11702296
[TBL] [Abstract][Full Text] [Related]
2. Androgenetic Alopecia: An Update of Treatment Options.
Kelly Y; Blanco A; Tosti A
Drugs; 2016 Sep; 76(14):1349-64. PubMed ID: 27554257
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Adil A; Godwin M
J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
[TBL] [Abstract][Full Text] [Related]
5. What's New in Therapy for Male Androgenetic Alopecia?
Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
[TBL] [Abstract][Full Text] [Related]
6. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
[TBL] [Abstract][Full Text] [Related]
8. A review of hormonal therapy for female pattern (androgenic) alopecia.
Scheinfeld N
Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
[TBL] [Abstract][Full Text] [Related]
9. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
10. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
11. Psychological effect, pathophysiology, and management of androgenetic alopecia in men.
Stough D; Stenn K; Haber R; Parsley WM; Vogel JE; Whiting DA; Washenik K
Mayo Clin Proc; 2005 Oct; 80(10):1316-22. PubMed ID: 16212145
[TBL] [Abstract][Full Text] [Related]
12. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
13. Current management of androgenetic alopecia in men.
Wolff H; Kunte C
Eur J Dermatol; 1999 Dec; 9(8):606-9. PubMed ID: 10586125
[TBL] [Abstract][Full Text] [Related]
14. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
[TBL] [Abstract][Full Text] [Related]
15. Management of androgenetic alopecia.
Tosti A; Camacho-Martinez F; Dawber R
J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
[TBL] [Abstract][Full Text] [Related]
16. Androgenetic alopecia: an update.
Kaliyadan F; Nambiar A; Vijayaraghavan S
Indian J Dermatol Venereol Leprol; 2013; 79(5):613-25. PubMed ID: 23974579
[TBL] [Abstract][Full Text] [Related]
17. [Androgenetic alopecia in the man].
Bader U; Trüeb RM
Ther Umsch; 2002 May; 59(5):211-6. PubMed ID: 12090116
[TBL] [Abstract][Full Text] [Related]
18. Dutasteride in Androgenetic Alopecia: An Update.
Arif T; Dorjay K; Adil M; Sami M
Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
[TBL] [Abstract][Full Text] [Related]
19. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS
J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531
[TBL] [Abstract][Full Text] [Related]
20. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
Marotta JC; Patel G; Carvalho M; Blakeney S
Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]